IRF4 is Correlated with the Conversion to a Th17-Like Phenotype in Regulatory T Cells from the Malignant Pleural Effusion
Wenqing Yu,Ningfei Ji,Chengjing Gu,Juan Yao,Mingdong Ding,Daming Zhou,Mao Huang,Mingshun Zhang
DOI: https://doi.org/10.2147/IJGM.S330389
IF: 2.145
2021-09-23
International Journal of General Medicine
Abstract:Wenqing Yu, 1, &ast Ningfei Ji, 2, &ast Chengjing Gu, 3, &ast Juan Yao, 4 Mingdong Ding, 1 Daming Zhou, 1 Mao Huang, 2 Mingshun Zhang 5, 6 1 Department of Infectious Diseases, Taizhou People's Hospital Affiliated to Nantong University, Taizhou, Jiangsu, 225300, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China; 3 Department of Pharmacy, Taizhou People's Hospital Affiliated to Nantong University, Taizhou, Jiangsu, 225300, People's Republic of China; 4 Department of Oncology, Huaian Hospital of Huaian City, Huaian, Jiangsu, 223200, People's Republic of China; 5 Department of Immunology, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China; 6 NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chengjing Gu Department of Pharmacy, Taizhou People's Hospital Affiliated to Nantong University, Taizhou, Jiangsu, 225300, People's Republic of China Tel +86 0523-86606290 Email Wenqing Yu Department of Infectious Diseases, Taizhou People's Hospital Affiliated to Nantong University, Taizhou, Jiangsu, 225300, People's Republic of China Email Background: RORγt + Foxp3 + (Th17-like) Tregs are a plastic Treg subset implicated in immune-related diseases; however, the mechanism of Treg phenotypic transformation in malignant pleural effusion (MPE) has not been elucidated. Methods: The percentage of CD4 + CD25 + Foxp3 + Helios + and RORγt + Foxp3 + Tregs from peripheral blood and pleural effusion mononuclear cells were measured. The level of interferon regulatory factor 4 (IRF4) mRNA expression was detected by quantitative real-time reverse transcription polymerase chain reaction. The effects of IRF4 on the induction of Tregs from patients with non-small cell lung cancer (NSCLC) were evaluated in vitro. Correlation assays between IRF4 expression and the frequency of RORγt + Foxp3 + Tregs were performed. Results: The frequency of CD4 + CD25 + Foxp3 + Helios + Tregs and CD4 + RORγt + Th17 cells was both increased in the MPE of NSCLC patients. The group of double-positive Foxp3 + RORγt + Treg phenotype were identified in the pleural effusion. A significant increase in the frequency of Foxp3 + RORγt + Tregs was found in MPE compared with the non-malignant pleural effusion (NPE). Compared to NPE, the relative level of IRF4 expression was increased in the MPE. IRF4 expression was positively associated with the frequency of Foxp3 + RORγt + Tregs in the PE. In vitro, the level of Helios mRNA and protein expression was reduced in induced Tregs following IRF4 over-expression. Additionally, the level of RORγt protein expression was substantially increased. However, ectopic Helios expression in induced Tregs reversed the effects induced by enhanced IRF4 expression. Conclusion: IRF4 may serve as a potential molecule that promotes the conversion of regulatory T cells from MPE to a Th17-like phenotype by modulating Helios. Keywords: malignant pleural effusion, lung cancer, IRF4, regulatory T cells, phenotypic transformation Malignant pleural effusion (MPE) is a complication of tumors that is most commonly caused by lung cancer. 1 The immunosuppressive state of the tumor microenvironment represents a challenge to overcoming the current dismal outcome of patients with advanced lung cancer. 2–4 However, various inhibitory factors derived from immune cells, including tumor-associated macrophages, bone-marrow-derived suppressor cells, and regulatory T cells (Tregs), especially in the intratumoral microenvironment, hinder therapeutic strategies by helping tumor cells to escape immune attack. 5,6 Studies have found that a variety of CD4 + T cell subsets, are enriched in the MPE of non-small cell lung cancer (NSCLC). 4,7–10 Tregs are a distinct subset of CD4 + T cells that function to prevent excessive inflammatory tissue damage and maintain immune tolerance. In addition, Tregs also promote tumor development and progress via both humoral and cellular mechanisms. Tregs facilitate MPE progression in both humans and animal models. 4,10,11 The alteration of the Tr -Abstract Truncated-
medicine, general & internal